Constraint Analysis and Bladder Wall Low-Dose-Constraint Reduction in Five-Fraction Urethra-Sparing Prostate SBRT
Open Access
- 1 January 2021
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in International Journal of Medical Physics, Clinical Engineering and Radiation Oncology
- Vol. 10 (03), 132-148
- https://doi.org/10.4236/ijmpcero.2021.103012
Abstract
Aim: To compare and analyze dose constraints and target coverage results and to reduce Bladder Wall (Bwall) V18.12 for prostate Stereotactic-Body Radiation Therapy (SBRT) when Seminal Vesicles (SSVV) are included or not. Several indicators based on intersection volumes are obtained to predict constraint fulfillment. Background: Due to prostate’s low alpha-beta ratio and the possibility of increasing the therapeutic ratio several moderate and extreme hypofractionation schemes have been proposed. The scheme selected was a fivefraction urethra-sparing prostate SBRT. Materials and Methods: 150 patients divided into two groups according to the inclusion of SSVV in PTV or not were analyzed. Histograms, average values, standard deviations and degrees of fulfillment were obtained for each constraint or goal and group. A possible reduction of the Bwall V18.12 was addressed by re-optimizing fifty randomly chosen patients. Predictors of constraint fulfilling were obtained by using the intersections of Bwall and Rectum Wall (Rwall) with the PTV. Results: Significant differences in Rwall V32.62 and V29 were obtained when evaluating the influence of SSVV inclusion. A reduction of 12% in the Bwall V18.12 constraint was achieved without compromising coverage and OARs doses. No dependence on the inclusion of SSVV was found. Conclusions: Statistically significant differences have been found in Rwall intermediate-dose constraint when SSVV was included. A reduction of 12% in the Bwall V18.12 constraint has been achieved without compromising the PTV coverage and the rest of OARs constraints. Constraint fulfillment predictors could be useful to evaluate the feasibility of prostate SBRT prior to the planning process for every single patient.Keywords
This publication has 37 references indexed in Scilit:
- Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceRadiation Oncology, 2013
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?International Journal of Radiation Oncology*Biology*Physics, 2013
- Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapyRadiation Oncology, 2012
- A Prospective Phase III Randomized Trial of Hypofractionation Versus Conventional Fractionation in Patients With High-Risk Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Is there a role for endorectal balloons in prostate radiotherapy? A systematic reviewRadiotherapy and Oncology, 2010
- A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patientsActa Oncologica, 2010
- Measuring Health-Related Quality of Life Consequences From Primary Treatment for Early-Stage Prostate CancerSeminars in Radiation Oncology, 2008
- Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation StudyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994